AMICAS approved to repurchase shares

TriMed Staff | | Health Imaging | Diagnostic Imaging
AMICAS Inc. has announced that its Board of Directors has approved the repurchase of as much as $15 million of the Company's common stock from the open market or privately negotiated transactions as needed, AMICAS said.
   
The schedule for such repurchases will be determined by the company's management. The transactions can also be made under a Rule 10b5-1 plan, which allows shares to be bought back in instances where company is otherwise not permitted to do so under insider trading laws.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.